Hepatopancreatobiliary Surgery Institute of Gansu Province

The Optimal Measurement Time for the New Gallbladder Function Assessment Method

Role: lead

Impact of Cardiopulmonary Bypass Time on Gastrointestinal Complications

Role: lead

A Strategy for Gallstone Expulsion Through Dietary Therapy

Role: lead

A Novel Strategy for Evaluating Gallbladder Contraction Function by Ultrasound

Role: lead

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Role: lead

Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

Role: lead

If Chronic Gallbladder Diseases Increase the Incidence of PEC

Role: lead

The Diagnostic Value of Nitrogen Element (N) in Esophagus Cancer

Role: lead

PMS Promotes the Recovery of Patients After Heart Valve Replacement

Role: lead

Photodynamic Therapy for Cholangiocarcinoma

Role: lead

Gallstones and Risk of Inflammatory Bowel Disease

Role: lead

The Incidence of Gallstones After Gastrectomy

Role: lead

The Incidence of Gallstones After Gastric Cancer Surgery

Role: lead

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Role: lead

Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

Role: lead

Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement

Role: lead

The Effect of Gallstone Characteristics for the Severity of Gallstone Pancreatitis

Role: lead

A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)

Role: lead

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Role: lead

A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)

Role: lead